Biohit Oyj — Board/Management Information 2016

Jul 5, 2016

Disclosure 343864

Biohit Oyj - Changes board/management/auditors

Changes to Biohit Oyj’s Management Team

Biohit Oyj Stock Exchange Release July 5, 2016 at 09:30 a.m. local time (EEST) M.Sc. (Tech.), Daniela Söderström (b. 1987) has been appointed as Quality and Regulatory Affairs Director and a member of the Management Team of Biohit Oyj as of July 5, 2016. She joined Biohit Oyj in 2014. In her new position she reports to CEO Semi Korpela. Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com